期刊文献+

BPH组织无症状性炎症的模式及临床意义 被引量:3

Asymptomatic inflammation in benign prostatic hyperplasia
下载PDF
导出
摘要 目的:揭示BPH患者前列腺组织无症状性炎症的模式及临床意义。方法:对40例BPH患者经TURP或开放手术获取的前列腺标本行白细胞共同抗原(LCA)免疫组织化学染色,并对前列腺组织内的炎细胞应用图像分析系统进行扫描,计算炎细胞面积占整个切片面积的百分比。结果:40例患者前列腺组织均有明显的炎细胞浸润,炎症模式分为腺周围型(34/40)、腺型(26/40)和基质型(23/40),约近一半的患者(18/40)在同一张切片上可以同时见到明显的二种甚至三种炎症类型改变。炎细胞面积在前列腺细菌培养阳性者和阴性者之间、术前留置导尿管者和未留置导尿管者之间的差异均无统计学意义(均P>0.05)。结论:BPH患者前列腺组织的炎细胞浸润是非常常见的组织学改变,这种无症状性前列腺炎与BPH关系密切,其临床意义有待进一步确定。 Objective:To determine the pattern and clinical significance of asymptomatic inflammation in benign prostatic hyperplasia (BPH).Methods:Histological sections were obtained from 40 cases of BPH specimens collected prospectively at transurethral resection of the prostate(TURP) or suprapubic prostatectomy. Leukocyte common antigen(LCA) was demonstrated by immunostaining and the percentage of inflammation tissue area in the total specimen were measured with a computerized image-analysis system.Results:Inflammation was identified in all patients. Foci of inflammation were categorized as periglandular(34/40), glandular(26/40)and stromal (23/40). There was no significant difference between any combination of inflammation pattern and extent in those culture-positive and culture-negative cases (P>(0.05)) or catheterized or not (P>(0.05)).Conclusions:Prostatic inflammation is an extremely common histological finding in patents with symptoms of BPH. The clinical significance of asymptomatic chronic prostatitis associated with BPH awaits further determination.
出处 《临床泌尿外科杂志》 2005年第6期334-336,共3页 Journal of Clinical Urology
关键词 前列腺炎 前列腺增生 免疫组织化学 Prostatitis Benign prostatic hyperplasia Immunohistochemistry
  • 相关文献

参考文献8

  • 1Collins M M, Stafford R S, O'Leary M P, et al. How common is prostatitis? A national survey of physician visits. J Urol, 1998,159:1224-1228.
  • 2Nickel J C. Prostatic inflammation in benign prostatic hyperplasia-the third component? Can J Urol, 1994, 1:1-4.
  • 3Nickel J C, Downey J, Young I, et al. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU International, 1999,84:976-981.
  • 4National Institutes of Health Summary Statement. National institute of health/national institute of diabetes and digestive and kidney disease workshop on chronic prostatitis. Bethesda. December,1995.
  • 5Nadler R B, Koch A E, Calhoun E A, et al. IL-1 β and TNF-a in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol, 2000,164: 214-218.
  • 6McNeal J E. Regional morphology and pathology of the prostate. Am J Clin Path, 1968, 49:347-357.
  • 7Maksem J A, Johenning P W, Galang C F. Prostatitis and aspiration biopsy cytology of prostate. Urology,1988, 32:263-268.
  • 8Kohnen P W, Drach G W. Patterns of inflammation in prostatic hyperplasia., a histologic and bacteriologic study. J Urol, 1979,121:755-760.

同被引文献30

  • 1Blumenfeld W,Tucci S,Narayan P.Incidental lymphocytic prostatitis.Selective involvement with nonmalignant glands[J].Am J Surg Path,1992,16(10):975-981.
  • 2Gerstenbluth RE,Steftel AD,MacLennan GT,et al.Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of Bcl-2 in areas of inflammation[J].J Urol,2002,167(5):2267-2270.
  • 3Stein G,Cessl A,Kramer G,et al.Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia[J].J Urol,1994,151(2):480-484.
  • 4Mishra VC,Allen DJ,Nicolaou C,et al.Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia[J].BJU Int,2007,100(2):327-331.
  • 5Chung SD, Huang CC, Lin HC. Chronic prostatitis and depres- sive disorder: a three year population-based study [ J ]. J Affect Disord, 2011,134 ( 1-3 ) :404-409.
  • 6Mishra VC, Allen D J, Nicolaou C, et al. Does intraprostatic in- flammation have a role in the pathogenesis and progression of be- nign prostatic hyperplasia[J]. BJU Int, 2007,100(2) :327-331.
  • 7Gerstenbluth RE, Steftel AD, MacLennan GT, et al. Distribu- tion of chronic Prostatitis in radicalprostatectomy specimens with up-regnlation of Bcl. 2 in areas of inflammation [ J ]. J Urol, 2002, 167(5) :2267-2270.
  • 8Vasto S, Carruba G, Candore G, et al. Inflammation and pros- tate cancer [ J ]. Future Oneol,2008,4 ( 5 ) :637-645.
  • 9Sciarra A, Mariotti G, Salciccia S, et al. Prostate growth and in- flammation[ J]. J Steroid Biochem Mol Biol, 2008,108 (3-5) :254-260.
  • 10Nickel JC, Roehrborn CG. Optimizing the management of pros- tate diseases: prostatitis and benign prostatic hyperplasia. Intro- duction [ J ]. BJU Int, 2008 , 101 ( Suppl 3) : 1.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部